BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung
,
Early pregnancy factor
,
Lipopolysaccharide
,
rs2300478
,
IL1A
,
Coagulation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cyp3a4 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
HepG2 liver carcinoma cells in response to inhibition of DNA methylation and histone deacetylation
Hepatocytes cultured in scaffolds of polystyrene, polyethylene glycol and microwell spheroids
Diseased liver tissue miRNA expression profiles
Hepatocyte gene expression in response to a time course of treatment with atorvastatin
Explore Curated Studies Results
Literature
Most Relevant Literature
Prediction of Sites of Metabolism of CYP3A4 Substrates Utilizing Docking-Derived Geometric Features.
CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients.
Clinical poisoning events involving yunaconitine may be highly correlated with metabolism-based inte…
Physiologically Based Pharmacokinetic Modeling to Simulate CYP3A4-Mediated Drug-Drug Interactions fo…
Characterization of Correction Factors to Enable Assessment of Clinical Risk from In Vitro CYP3A4 In…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on…
Vorapaxar in the Human Endotoxemia Model
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patie…
TMC435-TiDP16-C107: This Study Measures the (Possible) Influence of TMC435 on the Activity of a Sele…
First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ